NDAOPHTHALMICEMULSIONPriority Review
Approved
Jun 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DUREZOL (difluprednate ophthalmic) is a potent corticosteroid emulsion approved in 2008 for post-operative inflammation and corneal edema following cataract surgery. It works by inhibiting phospholipase A2, thereby suppressing prostaglandin and leukotriene production to reduce inflammatory responses including edema, capillary proliferation, and scar formation. The drug is indicated for cataracts, inflammation, corneal edema, retinal degeneration, and visual acuity reduction.
$0.343MPart D
LOE ApproachingProduct approaching loss of exclusivity with modest Part D utilization signals contraction phase, likely driving rationalization of brand team resources.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
DUREZOL currently shows zero linked job openings, indicating minimal active hiring for this mature, specialty-focused ophthalmic asset. Career growth opportunities are limited; roles would primarily focus on defensive market management, generic mitigation, and cost-containment rather than expansion.
Company
Worked on DUREZOL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.